Visual, Clinical, and Quality of Life Outcomes of a New Multifocal IOL
Study Overview
This study focuses on the BIOS Trifocal intraocular lens (IOL), designed to help patients see clearly at various distances without needing glasses. The lens aims to minimize issues like halos and glare, which can occur with other multifocal lenses.
Key Features of BIOS Trifocal IOL
- Single-piece acrylic design: Enhances stability and centration.
- Aspheric surface: Reduces visual distortions.
- Optimized diffraction grating: Distributes light effectively for clear vision at all distances.
Study Methods
Participants received the BIOS Trifocal IOL and were evaluated at 30 and 90 days after surgery. Assessments included:
- Patient-reported outcomes using the NEI-VFQ 25 questionnaire.
- Visual acuity tests for distance and near vision.
- Monitoring of any complications during and after the procedure.
Results
The results showed:
- Significant improvement in distance and near vision at both 30 and 90 days (p < 0.001).
- Functional vision maintained across a range of distances, from +1.5 D to -3.0 D.
- Quality of life improvements in all areas measured (p < 0.05).
- No major complications linked to the IOL.
Conclusions
The BIOS Trifocal IOL effectively treats cataracts and presbyopia, providing clear vision at various distances and high patient satisfaction.
Trial Registration
This trial is registered with the Brazilian Registry of Clinical Trials under code RBR-772s6y since April 6th, 2020.
Clinical Trial Importance
Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates crucial clinical information to support healthcare providers.
Enhancing Patient Care
In today’s healthcare landscape, efficient operations are vital. Our mobile apps assist with:
- Scheduling appointments
- Monitoring treatments
- Facilitating telemedicine services
By leveraging AI, clinics can streamline workflows, improve patient outcomes, and reduce paperwork. Discover more at aidevmd.com.
